Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagenase Santyl for Dermatome Wound Healing
NCT00651820Phase 4Completed
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Apr 2008
- Primary completion
- Nov 2009
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in surgical wound and scarring comparing Collagenase Santyl with Vehicle (2 arms). Primary endpoint: Time to Complete Wound Closure Collagenase Santyl and Vehicle at 21 days. Started Apr 2008; status: completed.
02
Drugs
collagenase
03
Conditions
surgical woundscarring
Beyond the preview
Go deeper on NCT00651820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651820.